Healthcare provider profile · identity verified

Eric Carl Pearson, MD

Family Practice · EAST GRAND FORKS, MN · NPI 1003835984

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	233	53
Amlodipine Besylate	Amlodipine Besylate	197	48
Hydrochlorothiazide	Hydrochlorothiazide	195	39
Metoprolol Succinate	Metoprolol Succinate	181	36
Simvastatin	Simvastatin	174	38
Lisinopril	Lisinopril	170	34
Omeprazole	Omeprazole	163	40
Losartan Potassium	Losartan Potassium	155	35
Levothyroxine Sodium	Levothyroxine Sodium	140	32
Duloxetine Hcl	Duloxetine Hcl	139	26
Gabapentin	Gabapentin	128	25
Tamsulosin Hcl	Tamsulosin Hcl	117	21
Tramadol Hcl	Tramadol Hcl	107	18
Metformin Hcl	Metformin Hcl	89	18
Metoprolol Tartrate	Metoprolol Tartrate	82	17
Furosemide	Furosemide	81	19
Donepezil Hcl	Donepezil Hcl	78	16
Pantoprazole Sodium	Pantoprazole Sodium	76	21
Metformin Hcl Er	Metformin Hcl	74	16
Jardiance	Empagliflozin	69	13
Clopidogrel	Clopidogrel Bisulfate	67	13
Potassium Chloride	Potassium Chloride	67	20
Finasteride	Finasteride	64	12
Rosuvastatin Calcium	Rosuvastatin Calcium	61	11
Escitalopram Oxalate	Escitalopram Oxalate	60	14
Methylphenidate Hcl	Methylphenidate Hcl	60	suppressed
Sertraline Hcl	Sertraline Hcl	60	12
Carvedilol	Carvedilol	57	13
Lorazepam	Lorazepam	55	20
Fluoxetine Hcl	Fluoxetine Hcl	54	11
Eliquis	Apixaban	51	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	suppressed
Mirtazapine	Mirtazapine	49	suppressed
Montelukast Sodium	Montelukast Sodium	49	suppressed
Prednisone	Prednisone	48	20
Spironolactone	Spironolactone	44	11
Albuterol Sulfate Hfa	Albuterol Sulfate	43	14
Ozempic	Semaglutide	41	suppressed
Trazodone Hcl	Trazodone Hcl	41	12
Xarelto	Rivaroxaban	39	suppressed
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Clonazepam	Clonazepam	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Topiramate	Topiramate	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Klor-Con M20	Potassium Chloride	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Trulicity	Dulaglutide	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	11
Glipizide	Glipizide	24	suppressed
Linzess	Linaclotide	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Diazepam	Diazepam	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Cephalexin	Cephalexin	19	13
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Digoxin	Digoxin	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Norethindrone Acetate	Norethindrone Acetate	12	suppressed
Nystatin	Nystatin	12	suppressed
Temazepam	Temazepam	12	suppressed
Valsartan	Valsartan	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Baclofen	Baclofen	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Naproxen	Naproxen	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error